Category: Uncategorised

A new updated “Oral Anti-Diabetic Therapy Guidelines for Type 2 Diabetes Mellitus” prescribing algorithm has been developed. This is very similar to the algorithm published in 2021. The main differences are:  1.  Prescribing of SGLT-2 inhibitors is simplified with Dapagliflozin replacing Empagliflozin/Canagliflozin. 2. There is an increased focus on cardiorenal protection. In essence, for people